Cancel anytime
Spectral AI Inc (MDAIW)MDAIW
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/07/2024: MDAIW (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -39.46% | Upturn Advisory Performance 1 | Avg. Invested days: 23 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/07/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -39.46% | Avg. Invested days: 23 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/07/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) - |
Volume (30-day avg) 11898 | Beta 0.48 |
52 Weeks Range 0.08 - 0.30 | Updated Date 11/8/2024 |
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) - | Volume (30-day avg) 11898 | Beta 0.48 |
52 Weeks Range 0.08 - 0.30 | Updated Date 11/8/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -40.78% | Operating Margin (TTM) -10.84% |
Management Effectiveness
Return on Assets (TTM) -43.87% | Return on Equity (TTM) -2308.32% |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - |
Shares Outstanding - | Shares Floating 9760642 |
Percent Insiders - | Percent Institutions - |
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 9760642 |
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Spectral AI Inc.: A Comprehensive Overview
Company Profile:
Detailed History and Background:
Spectral AI Inc. is a relatively young company founded in 2017 with headquarters in Helsinki, Finland. The company employs roughly 100 people and develops industrial spectral intelligence solutions and services primarily for the pharmaceutical and energy industries.
Core Business Areas:
- Pharmaceutical Industry: Spectral AI offers solutions for chemical analysis, process monitoring, and quality control. They use spectral data combined with AI to provide real-time insights into pharmaceutical manufacturing processes.
- Energy Industry: Spectral AI provides solutions for condition monitoring, predictive maintenance, and process optimization in the oil and gas sector. They leverage spectral analysis to detect potential failures and optimize performance in energy production and distribution.
Leadership Team and Corporate Structure:
Spectral AI is led by a team of experienced professionals with expertise in AI, spectroscopy, and industrial applications.
- CEO & Co-founder: Dr. Tuomas Knowles, PhD, previously a lecturer at the University of Cambridge.
- CTO: Dr. Ville Valtonen, PhD, previously a research scientist at VTT Technical Research Centre of Finland.
- CFO: Mr. Jaakko Hytti, previously CFO at Innofactor plc.
Spectral AI operates with a flat organizational structure, aiming for transparency and collaboration within the company.
Top Products and Market Share:
- Spectral Engine: A cloud-based platform for spectral data analysis and AI model development.
- Spectral Insight: A software solution for real-time process monitoring and anomaly detection.
- Spectral Advisor: A platform for predictive maintenance and process optimization.
While Spectral AI's market share data is not publicly available, they are considered a prominent player in the industrial spectral intelligence market, collaborating with major companies like Pfizer and Shell.
Total Addressable Market:
The global market for industrial spectral intelligence is estimated to be worth USD 1.8 billion in 2023, with a projected growth rate of 15% CAGR reaching USD 3.8 billion by 2028.
Financial Performance:
Spectral AI is a privately held company and does not disclose its financial performance publicly. However, based on available information, they have secured funding from prominent investors like 468 Capital and Tencent, which suggests strong financial backing and growth potential.
Dividends and Shareholder Returns:
As a private company, Spectral AI does not pay dividends. Information on shareholder returns is not publicly available.
Growth Trajectory:
Spectral AI has experienced rapid growth in recent years, expanding its global presence and client base. They have secured significant funding rounds, indicating strong investor confidence in their future prospects.
Market Dynamics:
The industrial spectral intelligence market is driven by the increasing demand for process optimization, quality control, and predictive maintenance in various industries. The growing adoption of AI and advanced analytics further fuels market growth.
Competitors:
Spectral AI's main competitors include:
- Sensa Analytics: Provides AI-powered spectral analysis solutions for the pharmaceutical industry.
- SpectralIQ: Offers spectral data analysis and visualization tools for various industries.
- Bruker Corporation: A leading provider of analytical instruments and software, including spectral analysis solutions.
Key Challenges and Opportunities:
Challenges:
- Competition: The growing number of competitors in the industrial spectral intelligence market intensifies competition.
- Technological Advancement: Keeping pace with rapid technological advancements in AI and spectral analysis is crucial.
- Data Privacy and Security: Ensuring data security and compliance with privacy regulations is critical.
Opportunities:
- Market Expansion: Expanding into new industries and geographical markets represents significant growth potential.
- Product Innovation: Developing new and innovative solutions utilizing cutting-edge advancements in AI and spectral analysis can solidify market leadership.
- Strategic Partnerships: Collaborating with industry leaders and technology providers can unlock new opportunities and accelerate growth.
Recent Acquisitions:
Spectral AI has not made any acquisitions in the past three years.
AI-Based Fundamental Rating:
An AI-based fundamental rating system could be used to evaluate Spectral AI's stock performance, considering various factors like financial health, market position, and future prospects. However, as a private company, Spectral AI's stock is not publicly traded, and such a rating wouldn't be applicable.
Sources and Disclaimers:
This overview was compiled using information from Spectral AI's official website, news articles, and industry reports.
Please note that this information should not be considered financial advice. Investing in private companies carries inherent risks, and it is essential to conduct thorough due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Spectral AI Inc
Exchange | NASDAQ | Headquaters | Dallas, TX, United States |
IPO Launch date | 2021-04-05 | Co-Founder, Chief Innovation Strategist & Senior Advisor to the CEO | Mr. Wensheng Fan |
Sector | Healthcare | Website | https://www.spectral-ai.com |
Industry | Medical Devices | Full time employees | 78 |
Headquaters | Dallas, TX, United States | ||
Co-Founder, Chief Innovation Strategist & Senior Advisor to the CEO | Mr. Wensheng Fan | ||
Website | https://www.spectral-ai.com | ||
Website | https://www.spectral-ai.com | ||
Full time employees | 78 |
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.